The clinical trials listed below are currently recruiting. Trials are held at centres throughout Australia including the GSK medicines Research Unit (located at the Prince of Wales Hospital in Randwick, Sydney). Please select 'More Information' to view specifics about the trial and the relevant contact details.

GSK Medicines Research Unit (Prince of Wales Hospital, Sydney)

Rheumatoid Arthritis
Study name: OFA110867 - Clinical Phase I/IIA study of subcutaneous administration of Ofatumumab in Rheumatoid Arthritis patients on stable dose Methotrexate. For more information please see the links below:

Advertisement
Letter of Interest
Calendar

Antibacterial
Study name: PDF111341 -  A Double-Blind, Parallel, Randomized, Placebo-Controlled, Single Dose Escalation First Time in Human Study to Investigate the Safety, Tolerability and Pharmacokintetics of GSK1322322 in Healthy Subjects. For more information please see the links below:

Advertisement
Letter of Interest
Calendar A
Calendar B
Calendar C

Other Australian Sites

Multiple Sclerosis
Study Name: A4M105038 - A phase II study to test the safety and effectiveness of a new oral medication for people with relapsing remitting Multiple Sclerosis.
More information

Rheumatoid Arthritis
Study name: OFA110635 - A phase III clinical trial of ofatumumab in adult patients with active rheumatoid arthritis on a stable dose of methotrexate.
More information

Non-Small Cell Lung Cancer
Study Name: 109493 (MAGRIT) - A Phase III study to assess the effectiveness of recMAGE-A3 +AS15 Antigen-Specific Cancer Immunotherapeutic as adjuvant therapy in patients with resectable MAGE-A3 positive Non-Small Cell Lung Cancer.
More information

Each trial has been approved by a Human Research Ethics Committee.